Outcomes for Patients With Head and Neck Sarcoma Treated Curatively With Radiation Therapy and Surgery

Overview

Journal Pract Radiat Oncol

Publisher Elsevier

Specialties Oncology
Radiology

Date 2024 Jun 8

PMID 38851534

Authors

Alison K Yoder

Ahsan Farooqi

Devarati Mitra

J Andrew Livingston

Dejka M Araujo

Erich M Sturgis

Ryan Goepfert

Andrew J Bishop

B Ashleigh Guadagnolo

Affiliations

Soon will be listed here.

Abstract

Purpose: Soft tissue sarcomas (STSs) of the head and neck (H&N) are rare malignancies that are challenging to manage. We sought to describe the outcomes of patients treated with curative intent using combined surgery and radiation therapy (RT) for H&N STS.

Methods And Materials: We performed a single-institution retrospective review of patients with nonmetastatic STS of the H&N who were treated from 1968 to 2020. The Kaplan-Meier method was used to estimate disease-specific survival (DSS) and local control (LC). Multivariable analyses (MVAs) were conducted using Cox proportional hazards model.

Results: One hundred ninety-two patients had a median follow-up of 82 months. Tumors arose in the neck (n = 50, 26%), paranasal sinuses (n = 36, 19%), or face (n = 23, 12%). Most patients were treated with postoperative RT (n = 134, 70%). Postoperative RT doses were higher (median, 60 Gy; preoperative dose, 50 Gy; P < .001). Treatment sequence was not associated with LC (preoperative RT, 78% [63%-88%]; postoperative RT, 75% [66%-82%]; P = .48). On MVA, positive/uncertain margin was the only variable associated with LC (hazard ratio [HR], 2.54; 95% CI, 1.34-4.82; P = .004). LC was significant on MVA (HR, 4.48; 95% CI, 2.62-7.67; P < .001) for DSS. Patients who received postoperative RT were less likely to experience a major wound complication (7.5% vs 22.4%; HR, 0.28; 95% CI, 0.11-0.68; P = .005). There was no difference in the rate of late toxicities between patients who received preoperative or postoperative RT.

Conclusions: H&N STS continues to have relatively poorer LC than STS of the trunk or extremities. We found LC to be associated with DSS. Timing of RT did not impact oncologic or long-term toxicity outcomes; however, preoperative RT did increase the chance of developing a major wound complication.

References

Shellenberger T, Sturgis E . Sarcomas of the head and neck region. Curr Oncol Rep. 2009; 11(2):135-42. DOI: 10.1007/s11912-009-0020-8. View

Levay J, OSullivan B, Catton C, Bell R, Fornasier V, Cummings B . Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys. 1993; 27(5):1091-9. DOI: 10.1016/0360-3016(93)90529-5. View

Kotecha S, Williams M, White H, Graystone J, Gibbons M, Cosker T . Head and neck sarcoma: three-year data from a tertiary referral centre. Ann R Coll Surg Engl. 2021; 103(10):762-767. PMC: 10335102. DOI: 10.1308/rcsann.2021.0119. View

Mucke T, Mitchell D, Tannapfel A, Holzle F, Kesting M, Wolff K . Outcome in adult patients with head and neck sarcomas--a 10-year analysis. J Surg Oncol. 2010; 102(2):170-4. DOI: 10.1002/jso.21595. View

Wang D, Zhang Q, Eisenberg B, Kane J, Li X, Lucas D . Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial. J Clin Oncol. 2015; 33(20):2231-8. PMC: 4486342. DOI: 10.1200/JCO.2014.58.5828. View

Tran L, Mark R, Meier R, Calcaterra T, Parker R . Sarcomas of the head and neck. Prognostic factors and treatment strategies. Cancer. 1992; 70(1):169-77. DOI: 10.1002/1097-0142(19920701)70:1<169::aid-cncr2820700127>3.0.co;2-f. View

Chaukar D, Deshmukh A, Majeed T, Chaturvedi P, Pai P, DCruz A . Factors affecting wound complications in head and neck surgery: A prospective study. Indian J Med Paediatr Oncol. 2014; 34(4):247-51. PMC: 3932590. DOI: 10.4103/0971-5851.125236. View

Roos J, Makitie A, Tarkkanen J, Ilmarinen T . Pretreatment tumor sampling and prognostic factors in patients with soft-tissue sarcoma of the head and neck. Eur Arch Otorhinolaryngol. 2021; 279(6):3147-3155. PMC: 9072459. DOI: 10.1007/s00405-021-07162-0. View

de Bree R, van der Waal I, de Bree E, Leemans C . Management of adult soft tissue sarcomas of the head and neck. Oral Oncol. 2010; 46(11):786-90. DOI: 10.1016/j.oraloncology.2010.09.001. View

10.

Davis A, OSullivan B, Turcotte R, Bell R, Catton C, Chabot P . Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005; 75(1):48-53. DOI: 10.1016/j.radonc.2004.12.020. View

11.

Barker Jr J, Paulino A, Feeney S, McCulloch T, Hoffman H . Locoregional treatment for adult soft tissue sarcomas of the head and neck: an institutional review. Cancer J. 2003; 9(1):49-57. DOI: 10.1097/00130404-200301000-00009. View

12.

Stiller C, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque M . Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer. 2012; 49(3):684-95. DOI: 10.1016/j.ejca.2012.09.011. View

13.

Guadagnolo B, Bassett R, Mitra D, Farooqi A, Hempel C, Dorber C . Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2022; 23(12):1547-1557. PMC: 9817485. DOI: 10.1016/S1470-2045(22)00638-6. View

14.

Yang J, Rosenberg S . Surgery for adult patients with soft tissue sarcomas. Semin Oncol. 1989; 16(4):289-96. View

15.

Singh R, Grimer R, Bhujel N, Carter S, Tillman R, Abudu A . Adult head and neck soft tissue sarcomas: treatment and outcome. Sarcoma. 2008; 2008:654987. PMC: 2276692. DOI: 10.1155/2008/654987. View

16.

Lewis J, Leung D, Heslin M, Woodruff J, Brennan M . Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol. 1997; 15(2):646-52. DOI: 10.1200/JCO.1997.15.2.646. View

17.

Mendenhall W, Mendenhall C, Werning J, Riggs C, Mendenhall N . Adult head and neck soft tissue sarcomas. Head Neck. 2005; 27(10):916-22. DOI: 10.1002/hed.20249. View

18.

Kraus D, Dubner S, Harrison L, Strong E, HAJDU S, Kher U . Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer. 1994; 74(2):697-702. DOI: 10.1002/1097-0142(19940715)74:2<697::aid-cncr2820740224>3.0.co;2-a. View

19.

Gorsky M, Epstein J . Head and neck and intra-oral soft tissue sarcomas. Oral Oncol. 1998; 34(4):292-6. View

20.

Salerno K, Alektiar K, Baldini E, Bedi M, Bishop A, Bradfield L . Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2021; 11(5):339-351. DOI: 10.1016/j.prro.2021.04.005. View